US · guidance

BOP Program Statement 1610.02 § 2

NALOXONE LOCATIONS AND INVENTORY MANAGEMENT

activein force · 2026-03-19 – presentact-effective-date

In addition to naloxone placement with all automated external defibrillators, each CEO or

designee is required to ensure nasal naloxone is carried by staff in key positions across our

facilities. The following personnel and posts will be equipped with nasal naloxone:

 All Lieutenants

 All Health Services staff, excluding Medical Referral Centers

 All Correctional Systems staff, including all mail room staff

 All Recreation staff

 All Unit Officers

 Special Housing Unit (SHU) Officer in Charge

 Compound and Corridor officers

 Visitation #1 post

 Front Lobby officers

Each CEO or designee will ensure the distribution of naloxone meets the following criteria:

 Accessibility by non-medical staff on all shifts.

 Accountability for the naloxone in all locations.

 Maintaining naloxone according to the storage conditions and requirements established by

the manufacturer.

Nitrile gloves will be stored with naloxone.

The Health Services Administrator (HSA) or designee will be responsible for ensuring naloxone

is maintained within the expiration date and for replacing expired or used containers. The CEO,

at non-institutional locations without an HSA, will determine the individual responsible. The

HSA or designee will obtain the medication through Bureau Pharmacy Services and maintain a

1610.02 3/19/2026 PROPERTY OF US GOVERNMENT 2

system of accountability such as the night stock system. See the Program Statement Pharmacy

Services for procedures for night stock utilization. The Pharmacist, local or remote fill, is

authorized to distribute naloxone nasal spray using a standing order from the Bureau Medical

Director as the prescriber in accordance with established policies, procedures, and protocols.

Health Services staff will issue the naloxone to the local staff member responsible for replacing

outdated or used devices.

The Bureau Chief Pharmacist or designee will provide guidance to non-institution locations

within the Bureau for the distribution of naloxone nasal spray.

History

PS 1610.02 dated 2026-03-19

Provenance

Source: bop.gov
Retrieved: 2026-09-20
Edition: bop-ps-2026-09-20
Content hash: 5445e2c26d20da8b83436dc56b799e53f5f49e587c62ba61979f3ea78895c206

View the official source →

The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.

Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.

Coverage · API docs